Quote 
Filter By
Filter By
Category: Reagents
Reference: R1005-.1
€0.00
(tax incl.)
Better performance of firefly luciferase mRNA modified by ARCA, 5mCTP and ΨUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
Reference: R1005-1
€0.00
(tax incl.)
Better performance of firefly luciferase mRNA modified by ARCA, 5mCTP and ΨUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
Reference: R1005-5
€0.00
(tax incl.)
Better performance of firefly luciferase mRNA modified by ARCA, 5mCTP and ΨUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
Reference: R1006-.1
€0.00
(tax incl.)
Used with guideRNA for site-specific DNA cleavage in genome editing
Reference: R1006-1
€0.00
(tax incl.)
Used with guideRNA for site-specific DNA cleavage in genome editing
Reference: R1006-5
€0.00
(tax incl.)
Used with guideRNA for site-specific DNA cleavage in genome editing
Reference: R1007-.1
€0.00
(tax incl.)
New modification with better performance --- direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control to study transfection and expression in mammalian cells.
Reference: R1007-1
€0.00
(tax incl.)
New modification with better performance --- direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control to study transfection and expression in mammalian cells.
Reference: R1007-5
€0.00
(tax incl.)
New modification with better performance --- direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control to study transfection and expression in mammalian cells.
Reference: R1008-.1
€0.00
(tax incl.)
5-moUTP-modified mRNA with better performance, Cy3 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.
Reference: R1008-1
€0.00
(tax incl.)
5-moUTP-modified mRNA with better performance, Cy3 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.
Reference: R1008-5
€0.00
(tax incl.)
5-moUTP-modified mRNA with better performance, Cy3 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.
Reference: R1009-.1
€0.00
(tax incl.)
5-moUTP-modified mRNA with better performance, Cy5 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.
Reference: R1009-1
€0.00
(tax incl.)
5-moUTP-modified mRNA with better performance, Cy5 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.
Reference: R1009-5
€0.00
(tax incl.)
5-moUTP-modified mRNA with better performance, Cy5 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.
Reference: R1010-.1
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation
Reference: R1010-1
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation
Reference: R1010-5
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation
Reference: R1011-.1
€0.00
(tax incl.)
EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation
Reference: R1011-1
€0.00
(tax incl.)
EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation
Reference: R1011-5
€0.00
(tax incl.)
EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation
Reference: R1012-.1
€0.00
(tax incl.)
Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
Reference: R1012-1
€0.00
(tax incl.)
Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
Reference: R1012-5
€0.00
(tax incl.)
Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
Reference: R1013-.1
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: R1013-1
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: R1013-5
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: R1015-.1
€0.00
(tax incl.)
Used with guideRNA for site-specific DNA cleavage in genome editing.
Reference: R1015-1
€0.00
(tax incl.)
Used with guideRNA for site-specific DNA cleavage in genome editing.
Reference: R1015-5
€0.00
(tax incl.)
Used with guideRNA for site-specific DNA cleavage in genome editing.
Reference: R1016-.1
€0.00
(tax incl.)
EGFP mRNA with Cap 1 structure, modified by 5-moUTP，providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: A1266-5
€0.00
(tax incl.)
MTOR inhibitor,potent,ATP-competitive and cell-permeable
Reference: R1016-1
€0.00
(tax incl.)
EGFP mRNA with Cap 1 structure, modified by 5-moUTP，providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: A1266-10
€0.00
(tax incl.)
MTOR inhibitor,potent,ATP-competitive and cell-permeable
Reference: R1016-5
€0.00
(tax incl.)
EGFP mRNA with Cap 1 structure, modified by 5-moUTP，providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: A1266-25
€0.00
(tax incl.)
MTOR inhibitor,potent,ATP-competitive and cell-permeable
Reference: R1017-.1
€0.00
(tax incl.)
mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: A1266-50
€0.00
(tax incl.)
MTOR inhibitor,potent,ATP-competitive and cell-permeable
Reference: R1017-1
€0.00
(tax incl.)
mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: R1017-5
€0.00
(tax incl.)
mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: R1018-.1
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.
Reference: K1024-1
€0.00
(tax incl.)
Inhibit proteolytic degradation during bacterium lysis and protein extraction
Reference: R1018-1
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.
Reference: K1024-20
€0.00
(tax incl.)
Inhibit proteolytic degradation during bacterium lysis and protein extraction
Reference: R1018-5
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.
Reference: R1001-.1
€0.00
(tax incl.)
Direct-detection reporter mRNA, used as control to study transfection and expression in mammalian cells.
Reference: K1024-50
€0.00
(tax incl.)
Inhibit proteolytic degradation during bacterium lysis and protein extraction
Reference: R1001-1
€0.00
(tax incl.)
Direct-detection reporter mRNA, used as control to study transfection and expression in mammalian cells.
Reference: K1024-100
€0.00
(tax incl.)
Inhibit proteolytic degradation during bacterium lysis and protein extraction
Reference: A1296-10
€0.00
(tax incl.)
Steroidal aromatase inhibitor,selective and irreversible
Reference: R1001-5
€0.00
(tax incl.)
Direct-detection reporter mRNA, used as control to study transfection and expression in mammalian cells.
Reference: A1296-5.1
€0.00
(tax incl.)
Steroidal aromatase inhibitor,selective and irreversible
Reference: R1020-.1
€0.00
(tax incl.)
Human erythropoietin (EPO) mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation.
Reference: A1296-25
€0.00
(tax incl.)
Steroidal aromatase inhibitor,selective and irreversible
Reference: R1020-1
€0.00
(tax incl.)
Human erythropoietin (EPO) mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation.
Reference: A1296-100
€0.00
(tax incl.)
Steroidal aromatase inhibitor,selective and irreversible
Reference: R1020-5
€0.00
(tax incl.)
Human erythropoietin (EPO) mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation.